Abstract
The in vitro anticancer screening of the medicated herbal formulation of podophyllum as reported earlier. The formulation of herbal syrup was prepared and optimized as per industrial practice guidelines and was subjected to in vitro anticancer assay against a A549-Human lung cancer cell line and MCF7-Huam Breast cancer cell line. The LC50, TGI and GI50 are reported here against standard Adriamycin used in the test. The result showed comparable activity of the herbal syrup of podophyllum extract.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Current Trends in Pharmacy and Pharmaceutical Chemistry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
